Group One Trading, L.P. Homology Medicines, Inc. Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$1.39 - $3.12 $53,071 - $119,124	38,181 Added 63.13%	98,662 $194,000
Q1 2022 May 12, 2022	BUY	$2.6 - $4.17 $103,295 - $165,669	39,729 Added 191.45%	60,481 $184,000
Q4 2021 Feb 11, 2022	SELL	$3.64 - $7.78 $10,596 - $22,647	-2,911 Reduced 12.3%	20,752 $76,000
Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $83,076 - $120,398	13,823 Added 140.48%	23,663 $186,000
Q2 2021 Aug 10, 2021	BUY	$6.02 - $9.64 $59,236 - $94,857	9,840 New	9,840 $72,000

Q1 2021 May 12, 2021	SELL	$9.17 - $14.8 $6,446 - $10,404	-703 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$8.92 - $13.29 $31,014 - $46,209	-3,477 Reduced 83.18%	703 $8,000
Q3 2020 Nov 12, 2020	BUY	$9.94 - $16.59 $41,549 - $69,346	4,180 New	4,180 $45,000
Q2 2020 Aug 13, 2020	SELL	$12.07 - $19.34 $61,255 - $98,150	-5,075 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$12.5 - $22.04 $30,775 - $54,262	2,462 Added 94.22%	5,075 $79,000
Q4 2019 Feb 10, 2020	BUY	$11.42 - $22.19 $29,840 - $57,982	2,613 New	2,613 $54,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.